LIVE SGP PPR

Mechanism of action

Amine compounds generally function through various mechanisms depending on their specific structure and target. Many amines act as neurotransmitters, influencing synaptic transmission in the central nervous system. For example, neurotransmitter amines such as dopamine and serotonin modulate mood, cognition, and behavior by binding to specific receptors and initiating intracellular signaling pathways.

Pharmacodynamics

The pharmacodynamics of amines can vary widely based on their specific type and structure. Generally, amines may affect various physiological systems by modulating receptor activity, enzyme function, and ion channel conductance. For example, catecholamines (a class of amines) can increase heart rate and blood pressure through adrenergic receptor activation. The overall effects depend on the target tissue and the receptor subtype involved.

Pharmacokinetics

The pharmacokinetics of amines can vary greatly due to their diverse structures. Generally, amines are absorbed through the gastrointestinal tract or by other routes of administration. They may undergo first-pass metabolism in the liver and have variable half-lives based on their chemical properties. Distribution in the body can be influenced by lipid solubility, with lipophilic amines having broader distribution. Excretion typically occurs via the kidneys, with some amines being metabolized into inactive forms before elimination.

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution should be exercised when administered to a nursing woman.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Clinical term 1
• Common term 1
• Clinical term 2
• Common term 2

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Dose acts by modulating the activity of specific neurotransmitter receptors and ion channels, influencing various physiological pathways. Its precise mechanism may involve interactions with G-protein coupled receptors, leading to downstream signaling effects that impact cellular responses.

Pharmacodynamics

Dose exhibits a range of effects depending on the dosage and target tissues. It is known to alter neurotransmitter release, affect ion conductance, and influence metabolic pathways, thereby contributing to its therapeutic efficacy and potential side effects.

Pharmacokinetics

Dose is generally absorbed following administration, with peak plasma concentrations occurring within a specified timeframe. Its distribution is influenced by tissue binding and permeability across cell membranes. The drug is metabolized primarily in the liver, with metabolites being excreted via renal and biliary routes. The half-life can vary based on individual patient factors, including age, liver function, and other concurrent medications.

Indications

• Source of high-quality protein
• Nutritional supplement for individuals with lactose intolerance (goat milk)
• Culinary use in various traditional dishes

Dosage

Children: Refer to dietary guidelines for protein intake based on age and nutritional needs.

Adults: Refer to dietary guidelines for protein intake based on individual nutritional needs.

Pharmacodynamics

Goat meat and milk provide essential amino acids, vitamins, and minerals necessary for human health. The protein content plays a vital role in muscle growth and repair. The lower fat content in goat meat compared to beef or lamb may lead to better cardiovascular health and lower cholesterol levels. Goat milk contains medium-chain fatty acids which can be metabolized more quickly for energy.

Pharmacokinetics

As a food product, goat meat is digested in the gastrointestinal tract, where enzymes break down proteins into amino acids, fats into fatty acids, and carbohydrates into simple sugars. Nutrients are then absorbed through the intestinal lining into the bloodstream. The specific absorption rates can vary based on the preparation and cooking methods used. Goat milk is absorbed similarly, with its fats being emulsified and digested efficiently due to its unique composition.

Pregnancy

There is no well-established information regarding the use of goat products during pregnancy. Caution is advised.

Breast-feeding

The safety of goat products during breastfeeding is not clearly established. Consult a healthcare provider for personalized advice.

Storage

Store goat products in a cool, dry place away from direct sunlight.

Indications

• Lactose intolerance
• As a filler or excipient in pharmaceutical formulations

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and clinical context.

Adults: Refer to the BNF for specific dosing information based on clinical context.

Mechanism of action

Lactose is metabolized in the intestine by the enzyme lactase into its constituent monosaccharides, glucose and galactose. In individuals with lactase deficiency, unabsorbed lactose passes into the colon, where it is fermented by bacteria, leading to gas production and osmotic effects that contribute to diarrhea.

Pharmacodynamics

The pharmacodynamics of lactose are primarily related to its effects on gastrointestinal function. In healthy individuals, lactose is effectively broken down into glucose and galactose, which are absorbed and utilized for energy. In individuals with lactose intolerance, the unabsorbed lactose can cause osmotic diarrhea and colonic fermentation, leading to discomfort and symptoms associated with lactose intolerance.

Pharmacokinetics

Lactose is not absorbed in the gastrointestinal tract until it is hydrolyzed into glucose and galactose by lactase. The absorption of glucose and galactose occurs in the small intestine. The half-life is not applicable as lactose is not typically administered as a medication but is rather ingested as a natural component of food. Its metabolism primarily occurs in the intestine.

Adverse effects

• Bloating
• Diarrhea
• Abdominal pain
• Flatulence

Precautions

• Use with caution in patients with lactose intolerance.
• Consider potential for gastrointestinal upset in sensitive individuals.

Pregnancy

Lactose is generally considered safe for use during pregnancy. However, consult a healthcare professional for individual advice.

Breast-feeding

Lactose is safe to use while breastfeeding, as it is a natural sugar present in breast milk.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Powder
• Granules
• Tablets
• Syrup

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Prevention of peste des petits ruminants in small ruminants
• Supportive care for infected sheep and goats

Dosage

Children: Refer to veterinary guidelines for specific dosing of vaccines and supportive treatments in young animals.

Adults: Refer to veterinary guidelines for specific dosing of vaccines and supportive treatments.

Mechanism of action

PPRV infects host cells by binding to the signaling lymphocyte activation molecule (SLAM) receptor on the surface of lymphocytes and other immune cells. This enables the virus to enter the cells and replicate, leading to cell death and impairment of the immune response. The resulting immune dysfunction contributes to the clinical manifestations of the disease.

Pharmacodynamics

The clinical signs of PPR are a result of the virus's impact on the immune system and respiratory tract. The disease leads to severe immunosuppression, making animals susceptible to secondary infections. Additionally, the destruction of epithelial cells in the respiratory and gastrointestinal tracts contributes to the symptoms observed during infection.

Pharmacokinetics

The pharmacokinetics of antiviral agents used in the management of PPR are not well defined due to the focus on vaccination and supportive care. Antiviral treatments, when used, would typically be administered based on the specific pharmacological properties of the agents chosen and the clinical condition of the affected animal.

Pregnancy

Limited data is available on the use of peste during pregnancy. Caution is advised.

Breast-feeding

Limited data is available on the excretion of peste in breast milk. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight. Ensure that the product is tightly closed.

Indications

• Petit mal seizures
• Absence seizures
• Generalized epilepsy

Dosage

Children: Refer to the BNF for Children for specific dosing information as it is dependent on the specific medication and the child's age and weight.

Adults: Refer to specific guidelines or the BNF for appropriate dosing information as it can vary based on the medication used.

Mechanism of action

The precise mechanism of action for the treatment of petit mal seizures typically involves modulation of neurotransmitter activity, particularly the enhancement of GABAergic transmission. This increases inhibitory neurotransmission in the brain, thereby stabilizing neuronal excitability and reducing the likelihood of seizure occurrence. Some antiepileptic drugs employed for this purpose may also affect sodium and calcium channels, further contributing to their anticonvulsant effects.

Pharmacodynamics

Pharmacodynamically, drugs used to treat petit mal seizures work by increasing the threshold for neuronal firing, thereby reducing the excitability of neurons. This helps to prevent the synchronous neuronal discharges that characterize seizures. The effectiveness of these medications can vary based on individual patient response, and they may also have sedative effects, which should be monitored.

Pharmacokinetics

The pharmacokinetics of antiepileptic drugs can vary widely. Generally, these medications are well-absorbed from the gastrointestinal tract and exhibit a range of half-lives. Metabolism often occurs in the liver, with some drugs undergoing extensive first-pass metabolism. Excretion typically happens through the kidneys, and dose adjustments may be necessary in patients with renal impairment. Monitoring plasma levels may be required for certain medications to ensure therapeutic efficacy while minimizing toxicity.

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and if the benefits outweigh the risks.

Breast-feeding

Caution is advised as it is not known if the drug is excreted in human milk.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Bovine respiratory disease
• Mastitis
• Metritis
• Bloat
• Coccidiosis
• Parasitic infections
• Nutritional deficiencies

Dosage

Children: Dosage for juvenile ruminants also varies based on the specific drug and condition. It is recommended to consult veterinary guidelines for appropriate dosing in young animals.

Adults: Dosage for adult ruminants varies widely based on the specific drug, condition being treated, and species. Refer to veterinary pharmacology resources for specific dosing information.

Mechanism of action

Ruminants digest food through a process called rumination, which involves regurgitating food, chewing it, and then swallowing it again. The rumen chamber houses a diverse population of bacteria, protozoa, and fungi that ferment ingested plant material, breaking down cellulose into simpler sugars and fatty acids. This microbial fermentation is crucial for the digestion of fibrous foods.

Pharmacodynamics

In ruminants, pharmacodynamics can vary significantly based on the unique physiology and microbiome of the animal. Drugs administered to ruminants may require careful consideration of their absorption and metabolism due to the extensive fermentation process in the rumen. The interaction between a drug and the ruminant's microbiota can influence the drug's efficacy and safety.

Pharmacokinetics

The pharmacokinetics of drugs in ruminants can be complex due to their unique digestive physiology. After administration, drugs may undergo significant alterations due to rumen fermentation, which can affect absorption, distribution, metabolism, and excretion. For example, some drugs may be degraded by ruminal microorganisms before they can exert their therapeutic effect, while others may be absorbed more slowly due to the presence of fibrous feed.

Dosage

Children: Refer to veterinary guidelines for appropriate dosing based on specific conditions and treatments.

Adults: Refer to veterinary guidelines for appropriate dosing based on specific conditions and treatments.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Influenza
• HIV/AIDS
• Hepatitis B and C
• Herpes simplex virus infections
• Cytomegalovirus infections
• COVID-19
• Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.